跳至主要内容
临床试验/EUCTR2017-000445-51-FR
EUCTR2017-000445-51-FR进行中(未招募)1 期

Efficiency of an antibioprophylaxy (levofloxacin) in patient treated by azacitidine - AZABAC

Centre Henri Becquerel0 个研究点目标入组 108 人开始时间: 2018年4月18日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
108

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age superior to 18 years old
  • patients treated by azacitidine for their myelodysplastic syndrome or acute myeloid leukaemia
  • ECOG inferior to 3
  • Life expectancy superior to 3 months
  • signed inform consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 54
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 54

排除标准

  • -allergy to quinolone
  • -previous event of tenopathy due to quinolone
  • -participation to another therapeutic clinical trial

研究者

相似试验